497 related articles for article (PubMed ID: 32405783)
1. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.
Katulanda P; Dissanayake HA; Ranathunga I; Ratnasamy V; Wijewickrama PSA; Yogendranathan N; Gamage KKK; de Silva NL; Sumanatilleke M; Somasundaram NP; Matthews DR
Diabetologia; 2020 Aug; 63(8):1440-1452. PubMed ID: 32405783
[TBL] [Abstract][Full Text] [Related]
2. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review.
Wicaksana AL; Hertanti NS; Ferdiana A; Pramono RB
Diabetes Metab Syndr; 2020; 14(5):1109-1120. PubMed ID: 32659694
[TBL] [Abstract][Full Text] [Related]
3. Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic.
Sacks LJ; Pham CT; Fleming N; Neoh SL; Ekinci EI
Diabetes Res Clin Pract; 2020 Aug; 166():108296. PubMed ID: 32623041
[TBL] [Abstract][Full Text] [Related]
4. Glucovigilance in COVID-19.
Lamptey R; Ahomagnon S; Acheampong F; Kalra S
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME
Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970
[TBL] [Abstract][Full Text] [Related]
6. Social isolation during Covid-19: Boon or bane to diabetes management.
Gupta S; Tang C; Higgs P
Diabetes Metab Syndr; 2020; 14(4):567-568. PubMed ID: 32413820
[No Abstract] [Full Text] [Related]
7. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
Zhou J; Tan J
Metabolism; 2020 Jun; 107():154216. PubMed ID: 32220612
[No Abstract] [Full Text] [Related]
8. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.
Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A
Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526
[No Abstract] [Full Text] [Related]
9. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
Preskorn SH
J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and COVID-19: Global and regional perspectives.
Jeong IK; Yoon KH; Lee MK
Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038
[TBL] [Abstract][Full Text] [Related]
11. Clinical considerations for patients with diabetes in times of COVID-19 epidemic.
Gupta R; Ghosh A; Singh AK; Misra A
Diabetes Metab Syndr; 2020; 14(3):211-212. PubMed ID: 32172175
[No Abstract] [Full Text] [Related]
12. Commentary: COVID-19 in patients with diabetes.
Hill MA; Mantzoros C; Sowers JR
Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
[No Abstract] [Full Text] [Related]
13. The Time of Uncertainty in Poland.
Dzida GJ
J Diabetes Sci Technol; 2020 Jul; 14(4):731-732. PubMed ID: 32460551
[No Abstract] [Full Text] [Related]
14. Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.
Pasquel FJ; Umpierrez GE
J Diabetes Sci Technol; 2020 Jul; 14(4):705-707. PubMed ID: 32370606
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and COVID-19 : Disease-Management-People.
Peric S; Stulnig TM
Wien Klin Wochenschr; 2020 Jul; 132(13-14):356-361. PubMed ID: 32435867
[TBL] [Abstract][Full Text] [Related]
16. The Coronavirus 2019 Pandemic and Diabetes: An International Perspective.
Klonoff DC
J Diabetes Sci Technol; 2020 Jul; 14(4):703-704. PubMed ID: 32517506
[No Abstract] [Full Text] [Related]
17. Relative Limited Impact of COVID-19 on Diabetes: A Personal View.
de Galan BE
J Diabetes Sci Technol; 2020 Jul; 14(4):727-728. PubMed ID: 32468834
[No Abstract] [Full Text] [Related]
18. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.
Zhang Y; Li H; Zhang J; Cao Y; Zhao X; Yu N; Gao Y; Ma J; Zhang H; Zhang J; Guo X; Liu X
Diabetes Obes Metab; 2020 Aug; 22(8):1443-1454. PubMed ID: 32406594
[TBL] [Abstract][Full Text] [Related]
19. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
[TBL] [Abstract][Full Text] [Related]
20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
